We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Uremic Toxins in the Intensive Care Unit (ICU): Patients With Sepsis

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified June 2015 by University Hospital, Ghent.
Recruitment status was:  Recruiting
Sponsor:
ClinicalTrials.gov Identifier:
NCT00752245
First Posted: September 15, 2008
Last Update Posted: June 3, 2015
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
University Hospital, Ghent
September 12, 2008
September 15, 2008
June 3, 2015
September 2008
December 2015   (Final data collection date for primary outcome measure)
Registration of toxin removal efficiency [ Time Frame: During dialysis ]
Same as current
Complete list of historical versions of study NCT00752245 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Uremic Toxins in the Intensive Care Unit (ICU): Patients With Sepsis
Study of the Kinetics of Uremic Toxins in the ICU Patients With Acute Renal Failure, in Order to Optimize the Dialysis Dose: Patients With Sepsis/Multi-organ Failure
Study of the kinetics of uremic toxins in the ICU patients with acute renal failure, in order to optimize the dialysis dose: patients with sepsis/multi-organ failure. The sampling of blood and dialysate will be done during dialyses with different durations (4, 6 and 8h)
Not Provided
Interventional
Not Provided
Allocation: Randomized
Intervention Model: Crossover Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
  • Renal Failure
  • Multi Organ Failure
  • Procedure: Dialysis during 4 hours
    Blood and dialysate sampling
  • Procedure: Dialysis during 6 hours
    Blood and dialysate sampling
  • Procedure: Dialysis during 8 hours
    Blood and dialysate sampling
  • Experimental: 1
    Dialysis during 4 hours
    Intervention: Procedure: Dialysis during 4 hours
  • Active Comparator: 2
    Dialysis during 6 hours
    Intervention: Procedure: Dialysis during 6 hours
  • Active Comparator: 3
    Dialysis during 8 hours
    Intervention: Procedure: Dialysis during 8 hours
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Unknown status
12
December 2015
December 2015   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  • ICU patients with sepsis/multi-organ failure with acute renal failure
Sexes Eligible for Study: All
18 Years and older   (Adult, Senior)
No
Contact information is only displayed when the study is recruiting subjects
Belgium
 
 
NCT00752245
2008/373
No
Not Provided
Not Provided
University Hospital, Ghent
University Hospital, Ghent
Not Provided
Principal Investigator: Raymond Vanholder, MD, PhD University Hospital, Ghent
University Hospital, Ghent
June 2015

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP